All four CID4 portfolio companies, Sophono, PeptiVir, VetDC and Flashback Technologies, have been accepted to present and participate in partnering discussions at the 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC).

Organized by the Colorado BioScience Association, the RMLIPC is the Rocky Mountain region’s premiere investor and partnering conference, attracting venture capital funds, corporate venture funds and business development leaders from the largest global biopharmaceutical and medical device companies – all convening in Denver, CO September 21-23, 2011. The conference incorporates a robust and competitive company selection process that is filtered by a national committee of life science investors and business development executives. The selection committee recently released names of the thirty companies hand-picked to attend and present over the course of the three-day conference.

CID4’s mission to advance the Colorado bioscience ecosystem through company creation and job growth is only partially fulfilled through project investment, it is the active management role that yields tangible progressive milestone-driven value, such as architecting early-stage company roadmaps and assisting in the raising of follow-on capital. Positioning a portfolio company in front of institutional capital and potential industry partners is a critical function played by CID4 management. Having Sophono, PeptiVir, VetDC and Flashback Technologies participate speaks to the quality of technologies emerging from Colorado and validates the CID4 project selection process which is driven by the industry professionals who generously volunteer their time and expertise as members of CID4’s Technical and Business Advisory Committee.”

“Our Association spearheads the investor and partnering conference every other year for the region. This is our second event, and we have been absolutely thrilled at the response from both companies applying to present and investors desiring to attend,” said Holli Riebel, President and CEO of the Colorado BioScience Association. “The selection of four CID4 Project companies to present at this year’s conference is a reflection of CID4’s role as more than just a source of investment capital, but also an active participant in the management of its Project companies.”